Auswahl der wissenschaftlichen Literatur zum Thema „Nr5a1“
Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an
Inhaltsverzeichnis
Machen Sie sich mit den Listen der aktuellen Artikel, Bücher, Dissertationen, Berichten und anderer wissenschaftlichen Quellen zum Thema "Nr5a1" bekannt.
Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.
Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.
Zeitschriftenartikel zum Thema "Nr5a1"
Shi, Boyang, Huijie Lu, Lihong Zhang und Weimin Zhang. „Nr5a1b promotes and Nr5a2 inhibits transcription of lhb in the orange-spotted grouper, Epinephelus coioides†“. Biology of Reproduction 101, Nr. 4 (17.07.2019): 800–812. http://dx.doi.org/10.1093/biolre/ioz121.
Der volle Inhalt der QuelleKUO, Ming-Wei, John POSTLETHWAIT, Wen-Chih LEE, Show-Wan LOU, Woon-Khiong CHAN und Bon-chu CHUNG. „Gene duplication, gene loss and evolution of expression domains in the vertebrate nuclear receptor NR5A (Ftz-F1) family“. Biochemical Journal 389, Nr. 1 (21.06.2005): 19–26. http://dx.doi.org/10.1042/bj20050005.
Der volle Inhalt der QuelleSuyama, Atsuhito, Nahoko Iwata, Yoshiaki Soejima, Yasuhiro Nakano, Koichiro Yamamoto, Takahiro Nada und Fumio Otsuka. „Involvement of NR5A1 and NR5A2 in the Regulation of Steroidogenesis by Clock Gene and BMPs by Human Granulosa Cells“. Journal of the Endocrine Society 5, Supplement_1 (01.05.2021): A768. http://dx.doi.org/10.1210/jendso/bvab048.1562.
Der volle Inhalt der QuelleSuzuki, Taiga, Megumi Kasahara, Hidefumi Yoshioka, Ken-ichirou Morohashi und Kazuhiko Umesono. „LXXLL-Related Motifs in Dax-1 Have Target Specificity for the Orphan Nuclear Receptors Ad4BP/SF-1 and LRH-1“. Molecular and Cellular Biology 23, Nr. 1 (01.01.2003): 238–49. http://dx.doi.org/10.1128/mcb.23.1.238-249.2003.
Der volle Inhalt der QuelleMartin, Luc J., und Jacques J. Tremblay. „Glucocorticoids antagonize cAMP-induced Star transcription in Leydig cells through the orphan nuclear receptor NR4A1“. Journal of Molecular Endocrinology 41, Nr. 3 (01.07.2008): 165–75. http://dx.doi.org/10.1677/jme-07-0145.
Der volle Inhalt der QuelleEmura, Natsuko, Chiung-Min Wang, William Harry Yang und Wei-Hsiung Yang. „Steroidogenic Factor 1 (NR5A1) Activates ATF3 Transcriptional Activity“. International Journal of Molecular Sciences 21, Nr. 4 (20.02.2020): 1429. http://dx.doi.org/10.3390/ijms21041429.
Der volle Inhalt der QuelleMorohashi, Ken-ichirou, Miki Inoue und Takashi Baba. „Coordination of Multiple Cellular Processes by NR5A1/Nr5a1“. Endocrinology and Metabolism 35, Nr. 4 (31.12.2020): 756–64. http://dx.doi.org/10.3803/enm.2020.402.
Der volle Inhalt der QuelleLuppino, Giovanni, Malgorzata Wasniewska, Roberto Coco, Giorgia Pepe, Letteria Anna Morabito, Alessandra Li Pomi, Domenico Corica und Tommaso Aversa. „Role of NR5A1 Gene Mutations in Disorders of Sex Development: Molecular and Clinical Features“. Current Issues in Molecular Biology 46, Nr. 5 (09.05.2024): 4519–32. http://dx.doi.org/10.3390/cimb46050274.
Der volle Inhalt der QuelleDomenice, Sorahia, Aline Zamboni Machado, Frederico Moraes Ferreira, Bruno Ferraz‐de‐Souza, Antonio Marcondes Lerario, Lin Lin, Mirian Yumie Nishi et al. „Wide spectrum of NR5A1‐related phenotypes in 46,XY and 46,XX individuals“. Birth Defects Research Part C: Embryo Today: Reviews 108, Nr. 4 (Dezember 2016): 309–20. http://dx.doi.org/10.1002/bdrc.21145.
Der volle Inhalt der QuelleShima, Yuichi, Kanako Miyabayashi, Takami Mori, Koji Ono, Mizuki Kajimoto, Hae Lim Cho, Hitomi Tsuchida et al. „Intronic Enhancer Is Essential for Nr5a1 Expression in The Pituitary Gonadotrope and for Postnatal Development of Male Reproductive Organs in a Mouse Model“. International Journal of Molecular Sciences 24, Nr. 1 (22.12.2022): 192. http://dx.doi.org/10.3390/ijms24010192.
Der volle Inhalt der QuelleDissertationen zum Thema "Nr5a1"
Fabbri-Scallet, Helena 1987. „Análise molecular do gene NR5A1 em pacientes 46,XY com distúrbios da diferenciação do sexo“. [s.n.], 2013. http://repositorio.unicamp.br/jspui/handle/REPOSIP/317065.
Der volle Inhalt der QuelleDissertação (mestrado) - Universidade Estadual de Campinas, Instituto de Biologia
Made available in DSpace on 2018-08-22T17:47:27Z (GMT). No. of bitstreams: 1 Fabbri_HelenaCampos_M.pdf: 5693726 bytes, checksum: f3da0b3f4f94d25ac46393e9f831a748 (MD5) Previous issue date: 2013
Resumo: O termo Distúrbio da Diferenciação do Sexo (DDS) caracteriza-se pelo desenvolvimento genital ou gonadal incompleto ou desordenado. Os DDS com cariótipo 46,XY são caracterizados por genitália externa ambígua ou feminina, em alguns casos com gônadas disgenéticas, e presença ou ausência de derivados de Müller. Os mais frequentes são a insensibilidade androgênica, deficiência da 5-alfa-redutase tipo 2, disgenesia gonadal e DDS ovário-testicular. Vários são os genes que participam dos processos de determinação e diferenciação do sexo. Alterações no gene NR5A1, que codifica o fator de transcrição SF- 1, é responsável por diferentes fenótipos de DDS. A proteína SF-1 é expressa principalmente em tecidos esteroidogênicos (gônadas, adrenais e placenta), nas células de Sertoli, nas células de Leydig e nos ovários; é o principal regulador do metabolismo do colesterol nas células esteroidogênicas. Além disso, regula a atividade de outros genes, como os CYPs, HSD3B, StAR, SOX9, DAX1, entre outros. Na literatura são descritas alterações no gene NR5A1 associadas à DDS 46,XY, anorquia bilateral, amenorréia primária, falência ovariana precoce, hipospádia, infertilidade masculina, e alguns casos de tumores adrenais e endometrioses. Neste trabalho foi realizada a análise molecular do gene NR5A1 em 86 pacientes com DDS 46,XY, incluindo-se disgenesia gonadal completa (n = 7), disgenesia gonadal parcial (n = 18), DDS 46,XY idiopático (n = 41) e outros (n = 20). Doze alterações foram identificadas neste trabalho, sendo: sete na região codificante (p.Ser32Asn, p.Arg39Cis, p.Lis38*, p.Cis65Tir, p.L80Wfs*8, p.Cis247*, and p.Asp364Trefs*18), uma em sítio de splicing (c.1138+1G>T), duas no exon 1 nãocodificante (c.-133G>A e c.-156_-136ins18pb), três na região 5'UTR (c.-413G>A, c.- 208C>A, e c.-762C>T) e uma na região 3'UTR (c.*1286C>T). As variações aqui descritas, não foram identificadas em controles saudáveis. As análises in silico demonstraram o possível efeito deletério de cada alteração e, suas relações com o fenótipo dos indivíduos. Embora estes resultados demonstrem a importância de cada alteração para o fenótipo, haverá ainda a necessidade de se investigar os efeitos funcionais in vitro. As alterações com potencial deletério foram identificadas em maior frequência nos casos dos distúrbios da diferenciação gonadal (20%) e DDS 46,XY idiopático (22%)
Abstract: The term Disorders of Sex Differentiation (DSD) characterize incomplete or disorganized genital or gonadal development. The DSD with 46, XY karyotype may present either ambiguous or female genitalia and also dysgenetic gonads in some cases, with presence or absence of Müllerian derivatives. The most frequent are androgen insensitivity, 5-alpha-reductase type 2 deficiency, gonadal dysgenesis and ovarian-testicular DSD. There are several genes that participate in both sex determination and differentiation processes. Mutations in NR5A1 gene, which encoding SF-1, a transcription factor, are responsible for different phenotypes of DSD. The protein SF-1, which is expressed mainly in steroidogenic tissues (gonads, adrenal glands and placenta), is also express in Sertoli and Leydig cells, in the ovaries, and is the major regulator of cholesterol metabolism in steroidogenic cells. Moreover, it regulates the activity of other genes, such as CYPs, HSD3B, StAR, SOX9, DAX1, among others. The literature describes the association of changes in NR5A1 gene with 46, XY DSD, bilateral anorchia, primary amenorrhea, premature ovarian failure, hypospadias, male infertility, and some cases of adrenal tumors and endometriosis. The present work involved the molecular analysis of NR5A1 gene in 86 patients with 46, XY DSD including complete gonadal dysgenesis (n = 7), partial gonadal dysgenesis (n = 18), idiopathic 46, XY DSD (n = 41) and others (n = 20). Twelve variations had been identified: seven in the coding region (p.Ser32Asn, p.Arg39Cis, p.Lis38*, p.Cis65Tir, p.L80Wfs*8, p.Cis247*, and p.Asp364Trefs*18), one at a splice site (c.1138+1 G>T), two in the noncoding exon 1 (c.-133G>A and c.-156_-136ins18pb), three in the 5'UTR region (c.- 413G>A, c.-208C>A and c.-762C>T) and one in the 3'UTR (c.*1286C>T). The variations herein described, have not been identified in healthy controls. In silico analysis showed possible deleterious effects for each change and its correlations to individual phenotypes. Although those results demonstrate the importance of each change for the phenotype, there in vitro functional effects must be investigated. The potentially deleterious changes were identified more frequently in cases of disorders of gonadal development (20%) and idiopathic 46, XY DSD (22%)
Mestrado
Genetica Animal e Evolução
Mestra em Genética e Biologia Molecular
Astudillo, Rebekka Anna-Maria [Verfasser]. „Funktionelle Charakterisierung von heterozygoten Mutationen des Steroidogenetischen Faktors 1 (SF1/NR5A1) bei 46,XY Störungen der Geschlechtsentwicklung / Rebekka Anna-Maria Astudillo“. Berlin : Medizinische Fakultät Charité - Universitätsmedizin Berlin, 2021. http://d-nb.info/1241538085/34.
Der volle Inhalt der QuelleKöhler, Birgit [Verfasser]. „XY Störungen der Geschlechtsentwicklung (XY DSD) : die Rolle des Wilms-Tumorsuppressorgens (WT1) und des „Steroidogenic Factor 1“ (NR5A1, SF1) sowie Langzeitergebnisse / Birgit Köhler“. Berlin : Medizinische Fakultät Charité - Universitätsmedizin Berlin, 2013. http://d-nb.info/1043480951/34.
Der volle Inhalt der QuelleTantawy, Sally [Verfasser]. „Untersuchung des Steroidogenic Factor 1 kodierenden Gens NR5A1 in einer Kohorte von 50 ägyptischen Patienten mit 46,XY Störungen der Geschlechtsentwicklung / Sally Moustafa Elsayed Tantawy“. Berlin : Medizinische Fakultät Charité - Universitätsmedizin Berlin, 2017. http://d-nb.info/1133074278/34.
Der volle Inhalt der QuelleTantawy, Sally Moustafa Elsayed [Verfasser]. „Untersuchung des Steroidogenic Factor 1 kodierenden Gens NR5A1 in einer Kohorte von 50 ägyptischen Patienten mit 46,XY Störungen der Geschlechtsentwicklung / Sally Moustafa Elsayed Tantawy“. Berlin : Medizinische Fakultät Charité - Universitätsmedizin Berlin, 2017. http://d-nb.info/1133074278/34.
Der volle Inhalt der QuelleGarner, Hannah Claire. „The role of Nr4a1 in the development of Ly6Clow monocytes“. Thesis, King's College London (University of London), 2016. https://kclpure.kcl.ac.uk/portal/en/theses/the-role-of-nr4a1-in-the-development-of-ly6clow-monocytes(bdc403c1-200f-4b12-8617-4cc23ce46171).html.
Der volle Inhalt der QuelleHofsten, Jonas von. „Developmental and reproductive regulation of NR5A genes in teleosts“. Doctoral thesis, Umeå : Univ, 2004. http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-374.
Der volle Inhalt der QuelleWilcots, Josiah. „Determination of induction of Nur77 (NR4A1), Nor1 (NR4A3), and Nurr1 (NR4A2)“. Master's thesis, Mississippi State : Mississippi State University, 2009. http://library.msstate.edu/etd/show.asp?etd=etd-04032009-165154.
Der volle Inhalt der QuelleSchwaderer, Juliane [Verfasser]. „LRH-1/NR5a2 in regulation of the immune system / Juliane Schwaderer“. Konstanz : Bibliothek der Universität Konstanz, 2017. http://d-nb.info/1140736418/34.
Der volle Inhalt der QuelleEdey, Caitlin. „Retinoid-mediated Regulation of NR6A1, Prickle1 and Ror2 During Development of the Mouse Embryo“. Thèse, Université d'Ottawa / University of Ottawa, 2012. http://hdl.handle.net/10393/23609.
Der volle Inhalt der QuelleBuchteile zum Thema "Nr5a1"
Grgurevic, Neza, und Gregor Majdic. „NR5a1“. In Encyclopedia of Signaling Molecules, 3574–84. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-67199-4_101872.
Der volle Inhalt der QuelleGrgurevic, Neza, und Gregor Majdic. „NR5a1“. In Encyclopedia of Signaling Molecules, 1–11. New York, NY: Springer New York, 2016. http://dx.doi.org/10.1007/978-1-4614-6438-9_101872-1.
Der volle Inhalt der QuelleMcElreavey, Ken, und Anu Bashamboo. „Steroidogenic Factor 1 (SF-1; NR5A1)“. In Encyclopedia of Endocrine Diseases, 415–20. Elsevier, 2019. http://dx.doi.org/10.1016/b978-0-12-801238-3.65242-x.
Der volle Inhalt der QuelleBashamboo, A., L. Lin, B. Ferraz de Souza, D. Lourenco, D. Montjean, C. Ravel, H. Rouba, J. Achermann und K. McElreavey. „Mutations in NR5A1 Encoding Steroidogenic Factor 1 Are Associated with Spermatogenic Failure.“ In The Endocrine Society's 92nd Annual Meeting, June 19–22, 2010 - San Diego, P2–367—P2–367. Endocrine Society, 2010. http://dx.doi.org/10.1210/endo-meetings.2010.part2.p8.p2-367.
Der volle Inhalt der QuelleFerraz-de-Souza, B., L. Lin und JC Achermann. „A Role for Steroidogenic Factor-1 (SF-1, NR5A1, Ad4BP) in Adrenal Angiogenesis.“ In The Endocrine Society's 92nd Annual Meeting, June 19–22, 2010 - San Diego, P1–612—P1–612. Endocrine Society, 2010. http://dx.doi.org/10.1210/endo-meetings.2010.part1.p13.p1-612.
Der volle Inhalt der QuelleFranca, Monica Malheiros, Mariza Gerdulo Santos und Claudimara Ferini Pacicco Lotfi. „Sf-1/NR5A1 and Pod-1/TCF21 Expression in Different Human Adrenocortical Tumor Cell Cultures“. In The Endocrine Society's 93rd Annual Meeting & Expo, June 4–7, 2011 - Boston, P1–628—P1–628. The Endocrine Society, 2011. http://dx.doi.org/10.1210/endo-meetings.2011.part2.p14.p1-628.
Der volle Inhalt der Quelle„SF-1 (Ftz-F1, fushi tarazu factor homolog, nuclear receptor subfamily 5 group A member 1[NR5A1])“. In Encyclopedia of Genetics, Genomics, Proteomics and Informatics, 1801. Dordrecht: Springer Netherlands, 2008. http://dx.doi.org/10.1007/978-1-4020-6754-9_15507.
Der volle Inhalt der QuelleLin, Lin, Rahul Parnaik, Bruno Ferraz-de-Souza und John C. Achermann. „Novel Interacting Proteins for Steroidogenic Factor-1 (SF-1, NR5A1, Ad4BP) in the Developing Human Adrenal Gland“. In BASIC/TRANSLATIONAL - Gene Regulation: Inflammation, Stress & Metabolism, P3–85—P3–85. The Endocrine Society, 2011. http://dx.doi.org/10.1210/endo-meetings.2011.part3.p21.p3-85.
Der volle Inhalt der QuelleEl-Khairi, Ranna, Alejandro Martinez-Aguayo, Bruno Ferraz-de-Souza, Lin Lin und John C. Achermann. „Role of DAX-1 (NR0B1) and Steroidogenic Factor-1 (NR5A1) in Human Adrenal Function“. In Pediatric Adrenal Diseases, 38–46. S. Karger AG, 2010. http://dx.doi.org/10.1159/000321213.
Der volle Inhalt der QuelleDemura, Masashi, Fen Wang, Takashi Yoneda, Shigehiro Karashima, Shunsuke Mori, Masashi Oe, Mitsuhiro Kometani et al. „Multiple Noncoding Exons 1 of Nuclear Receptors NR4A Family (NGFIB,NURR1,NOR1) and NR5A1 (SF1) in Human Vascular and Adrenal Tissues“. In BASIC - Regulation of Nuclear Receptors & Gene Expression, P2–8—P2–8. The Endocrine Society, 2011. http://dx.doi.org/10.1210/endo-meetings.2011.part2.p21.p2-8.
Der volle Inhalt der QuelleKonferenzberichte zum Thema "Nr5a1"
Wang, Chiung-Min, Victoria Brennan, Ninoska Gutierrez, Xirui Wang, Lizhong Wang und Wei-Hsiung Yang. „Abstract 763A: SUMOylation of ATF3 alters MC2R, NR5A1, STAR, and TP53 gene activities.“ In Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DC. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/1538-7445.am2013-763a.
Der volle Inhalt der QuelleMAIA DE SOUSA, LIZANDRA, MARICILDA PALANDI DE MELLO und Luiz Filipe Barbosa-Martins. „BUSCA DE NOVAS MUTAÇÕES NO GENE NR5A1 EM UM GRUPO DE HOMENS INFÉRTEIS.“ In XXIV Congresso de Iniciação Científica da UNICAMP - 2016. Campinas - SP, Brazil: Galoa, 2016. http://dx.doi.org/10.19146/pibic-2016-50634.
Der volle Inhalt der QuelleJin, Jingling, Roma Patel, Nan Ge Jin, Yan Shi, Wenjing Sun, Jianhua Yang, Jed G. Nuchtern und Sanjeev A. Vasudevan. „Abstract B16: NR5A2 as a potential therapeutic target for hepatoblastoma“. In Abstracts: AACR Special Conference: Advances in Pediatric Cancer Research: From Mechanisms and Models to Treatment and Survivorship; November 9-12, 2015; Fort Lauderdale, Florida. American Association for Cancer Research, 2016. http://dx.doi.org/10.1158/1538-7445.pedca15-b16.
Der volle Inhalt der QuelleNissim, Sahar, Julia Wucherpfennig, Xiao-Xu Wang, Alec Kimmelman und Wolfram Goessling. „Abstract 1953: The role of NR5a2 in pancreas development and carcinogenesis“. In Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA. American Association for Cancer Research, 2014. http://dx.doi.org/10.1158/1538-7445.am2014-1953.
Der volle Inhalt der QuelleNissim, Sahar, Julia Wucherpfennig, Xiao-Xu Wang, Alec Kimmelman und Wolfram Goessling. „Abstract 2657: The role of NR5A2 in pancreas development and oncogenesis.“ In Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DC. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/1538-7445.am2013-2657.
Der volle Inhalt der QuelleBeeghly-Fadiel, Alicia, Dajah Chase, Johnathan Cooks, Marta Crispens, Dineo Khabele und Andrew J. Wilson. „Abstract A42: TR3/NR4A1 as a therapeutic target for ovarian cancer“. In Abstracts: AACR Special Conference: Addressing Critical Questions in Ovarian Cancer Research and Treatment; October 1-4, 2017; Pittsburgh, PA. American Association for Cancer Research, 2018. http://dx.doi.org/10.1158/1557-3265.ovca17-a42.
Der volle Inhalt der QuelleNissim, Sahar, Olivia Weeks, John Hedgepeth, Julia Wucherpfennig, Xiao-Xu Wang, Alec Kimmelman und Wolfram Goessling. „Abstract 5148: NR5A2 is essential for pancreas development and affects pancreas carcinogenesis“. In Proceedings: AACR 106th Annual Meeting 2015; April 18-22, 2015; Philadelphia, PA. American Association for Cancer Research, 2015. http://dx.doi.org/10.1158/1538-7445.am2015-5148.
Der volle Inhalt der QuelleBeeghly-Fadiel, Alicia, Johnathan Cooks, Dajah Chase, Marta Crispens, Dineo Khabele und Andrew J. Wilson. „Abstract NT-088: PROGNOSTIC SIGNIFICANCE OF NR4A1/TR3 EXPRESSION IN OVARIAN CANCER“. In Abstracts: 12th Biennial Ovarian Cancer Research Symposium; September 13-15, 2018; Seattle, Washington. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/1557-3265.ovcasymp18-nt-088.
Der volle Inhalt der QuelleMohankumar, Kumaravel, Keshav Karki, Stephen Safe und Maen Abdelrahim. „Abstract 1149: Nuclear receptor 4A1 (NR4A1) antagonists target PD-L1 in colon cancer“. In Proceedings: AACR Annual Meeting 2021; April 10-15, 2021 and May 17-21, 2021; Philadelphia, PA. American Association for Cancer Research, 2021. http://dx.doi.org/10.1158/1538-7445.am2021-1149.
Der volle Inhalt der QuelleKarki, Keshav, Gus Wright, Jin Un-Ho, Kumaravel Mohankumar, Xing Zhang und Stephen Safe. „Abstract B41: Bis-indole derived NR4A1 antagonist induces PD-L1 degradation and enhances antitumor immunity“. In Abstracts: AACR Special Conference on Tumor Immunology and Immunotherapy; November 17-20, 2019; Boston, MA. American Association for Cancer Research, 2020. http://dx.doi.org/10.1158/2326-6074.tumimm19-b41.
Der volle Inhalt der Quelle